India, March 6 -- Eris Lifesciences Limited, a leading Indian branded formulations manufacturing companyhas appointed Murari Ranganathan as President, Cardiometabolic Business. He will be based out of the company's Mumbai office and take charge of the company's Anti-Diabetes and Cardiology businesses.

Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited. He joined Abbott in 2010 as Head Sales, Medical Nutrition and played a variety of roles in his 15-year stint with the Company.

Prior to Abbott, he has worked with organisations like Baxter, Novo Nordisk, and Torrent Pharma. He has a bachelor's in physics and mathematics from Bangalore University and ha...